Skip to main content
Equibles

MACKENZIE FINANCIAL CORP

Position in ARDX — Ardelyx, Inc.

CIK 919859 TORONTO ONTARIO, A6
Back to ARDX Full portfolio

Position in ARDX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,417,879
+$1,254,503 QoQ
Shares Held
474,094
+137.6% QoQ
Ownership
0.190%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 250 holders
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MACKENZIE FINANCIAL CORP holds $499,025,453 across 60 Biotechnology names. ARDX ranks #31 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 135,783 $84,666,131
2 INCY
Incyte Corp
 634,862 $71,967,956
3 BMRN
Biomarin Pharmaceutical Inc
 931,864 $53,321,258
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 102,928 $51,127,425
5 BBIO
BridgeBio Pharma, Inc.
 298,440 $22,227,811
6 TBPH
Theravance Biopharma, Inc.
 985,848 $16,759,416
7 RPRX
Royalty Pharma plc
 270,457 $15,164,523
8 ALNY
Alnylam Pharmaceuticals, Inc.
 43,988 $13,241,707

All Filings in ARDX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,417,879 474,094
2025-12-31 $1,163,376 199,550
2025-09-30 $974,360 176,835
2025-06-30 $865,849 220,880
2025-03-31 $732,365 149,158
2024-12-31 $710,474 140,133
2024-09-30 $263,831 38,292
2024-06-30 $217,142 29,304
2024-03-31 $219,160 30,022
2023-12-31 $187,667 30,269
2023-09-30 $116,936 28,661
2023-06-30 $97,160 28,661